CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active

$0.37

+$0.00(+0.46%)

Market Cap$4542787

P/E Ratio—

52W High$3.232

52W Low$0.271

Avg Volume81K

Open$0.37

Beta0.64

Overview

CollPlant Biotechnologies Ltd. (CLGN) Revenue

Annual & quarterly revenue history · segment & region breakdown

CLGN · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

CollPlant Biotechnologies Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

11.68×

mktCap ÷ TTM rev

Revenue per day

$0M

Est. TTM ÷ 365

Revenue / employee

$7K

57 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · CollPlant Biotechnologies Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

CLGN revenue by year · CLGN revenue history · CLGN annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CollPlant Biotechnologies Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CollPlant Biotechnologies Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CollPlant Biotechnologies Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

CLGN revenue · 4 questions

CLGN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CLGN revenueCLGN annual revenuewhat is CLGN revenueCLGN TTM revenue

▸ Source: FMP · CollPlant Biotechnologies Ltd. SEC filings · GAAP · CollPlant Biotechnologies Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026